Enzo Biochem Schedules Teleconference to Discuss Fiscal 2009 First Quarter Results on Thursday, December 11, 2008, at 8:30 AM E.T.

NEW YORK--(BUSINESS WIRE)-- Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss its fiscal 2009 first quarter results on Thursday, December 11, 2008, at 8:30 AM ET.

To listen to the conference call dial 1-877-258-8832. International callers can dial 1-973-321-1019. When prompted, use PIN number 77230186. Dial in approximately ten minutes prior to the scheduled teleconference time. A rebroadcast of the call will be available starting two hours after the conference call ends, through midnight (ET) Thursday, December 25, 2008. The replay of the conference call can be accessed by dialing 1-800-642-1687 (International callers can dial 1-706-645-9291) and, when prompted, use the same PIN number 77230186.

A press release announcing fourth quarter results will be distributed after the market close on Wednesday, December 10, 2008.

Enzo's conference call can also be accessed live over the Internet at http://www.investorcalendar.com. To listen to the live call, individuals should go to the web site at least 15 minutes early to register, download and install any necessary audio software. A replay on the Vcall website will be available for one week after the original broadcast.

Enzo Biochem is engaged in the research, development and manufacture of innovative health care products based on molecular biology and genetic engineering techniques, and in providing diagnostic services to the medical community.

Except for historical information, the matters discussed in this news release may be considered 'forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include declarations regarding the intent, belief or current expectations of the Company and its management. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties that could materially affect actual results. The Company disclaims any obligations to update any forward-looking statement as a result of developments occurring after the date of this press release.

    Source: Enzo Biochem, Inc.